ONC

BeOne Medicines Ltd.

SEC CIK 1651308
$264.48 −24.9% · 90 days
90-day buys
$0
0 open-market
90-day sells
$2.38M
10 open-market
Net insider flow
−$2.38M
Net selling
Filings shown
10
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at ONC have sold a net $2.38M of stock (0 open-market buys vs 10 sells).

Largest recent trade: Oyler John sold $1.03M of ONC, trimming their stake 77%.

Insider transaction history

Form 4 filings for ONC, newest first
View on SEC EDGAR ↗
ONC
Sell Ball Titus B. · Principal Accounting Officer · Open-market sale · filed 3d ago ΔOwn −74%

Ball Titus B. sold $27.1K of ONC, trimming their stake 74%.

−$27.1K
100 sh @ $271
ONC
Sell Ball Titus B. · Principal Accounting Officer · Open-market sale · filed 3d ago ΔOwn −100%

Ball Titus B. sold $9.8K of ONC, trimming their stake 100%.

−$9.8K
36 sh @ $272
ONC
Sell Lee Chan Henry · SVP, General Counsel · Open-market sale · filed 3d ago ΔOwn −82%

Lee Chan Henry sold $192.1K of ONC, trimming their stake 82%.

−$192.1K
711 sh @ $270
ONC
Sell Lee Chan Henry · SVP, General Counsel · Open-market sale · filed 3d ago ΔOwn −100%

Lee Chan Henry sold $43.4K of ONC, trimming their stake 100%.

−$43.4K
160 sh @ $271
ONC
Sell Wang Lai · President, Global Head of R&D · Open-market sale · filed 3d ago ΔOwn −97%

Wang Lai sold $357.4K of ONC, trimming their stake 97%.

−$357.4K
1,327 sh @ $269
Advertisement
ONC
Sell Wang Lai · President, Global Head of R&D · Open-market sale · filed 3d ago ΔOwn −100%

Wang Lai sold $10.8K of ONC, trimming their stake 100%.

−$10.8K
40 sh @ $271
ONC
Sell Wu Xiaobin · President and COO · Open-market sale · filed 3d ago ΔOwn −97%

Wu Xiaobin sold $388.9K of ONC, trimming their stake 97%.

−$388.9K
1,444 sh @ $269
ONC
Sell Wu Xiaobin · President and COO · Open-market sale · filed 3d ago ΔOwn −100%

Wu Xiaobin sold $10.8K of ONC, trimming their stake 100%.

−$10.8K
40 sh @ $271
ONC
Sell OYLER JOHN · Director, Chief Executive Officer · Open-market sale · filed 3d ago ΔOwn −77%

Oyler John sold $1.03M of ONC, trimming their stake 77%.

−$1.03M
3,820 sh @ $270
ONC
Sell OYLER JOHN · Director, Chief Executive Officer · Open-market sale · filed 3d ago ΔOwn −100%

Oyler John sold $303.7K of ONC, trimming their stake 100%.

−$303.7K
1,120 sh @ $271
Advertisement

About ONC insider activity

This page tracks every recent Form 4 filed for BeOne Medicines Ltd. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is ONC insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for BeOne Medicines Ltd. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.